ESR1 and breast carcinoma: By conducting a sequential functional genomic screen in a non-transformed breast cell line and two cell lines modeling primary and MBC, along with a metabolomic analysis in BC cells, we discovered that glutamine is overexpressed in ERα-positive breast cancer cells.